Dentist appointment today and time to refuse my dental x-rays!

I am such a difficult patient.

Teaching 'classic biases' tomorrow; does anyone have a great example of a recall bias affecting a study results?

I keep expecting to find a funny/impactful/memorable one but no luck thus far

I’m seeing some “free market” simps defending Nature’s 12k open access fees. Guess it’s time to bring this back around.

Kicking off #vasculitis24 !

Trying to figure out an average 'cost' for CT of the chest and PET-CT of the body. Does anyone have a good citation for this? Hoping for the cost in America in the 2020s.

So accurate. Notable that the Methods - easily the most important thing to read - didn’t even make the muscle-bro cut 😂😁🙄

It was a pleasure to write about future therapies for ANCA-associated vasculitis The Lancet Rheumatology: from RTX to CAR-T, bispecific antibodies, and precision cellular therapies.

Amazing team w Ulrich Specks, Sam Falde, MD Lynn Fussner Erin K O'Brien MD Henry Tazelaar.

authors.elsevier.com/a/1isC89UBHvrs…

Kudos to Mats Junek for getting this out. No detectable effect of plasma exchange or reduced GC dosing on relapse in #pexivas suggest treatment decisions based on kidney failure/ infection effects still main consideration (@DrRonWald, Peter Merkel) acrjournals.onlinelibrary.wiley.com/doi/10.1002/ar…

Challenging read NEJM; have to admit that I usually tell the medical students everything 😅

nejm.org/doi/pdf/10.105…

The algorithm seems to know that I would have loved to attend this talk, all over my feed

Was this recorded? Would love to watch this, trying to improve my own observational projects!

Miguel Hernán Lucy D’Agostino McGowan

Good year - great options! Just submitted my bracket :)

Thanks #RheumMadness team!

Thanks for participating! Really enjoyed the conversation

Great thoughts on risk/benefits of screening, ideal mgmt for pts w/ILD, importance of detection, etc

Have a listen! Links: ebrheum.com

Great read, strongly recommend - very cool charts / graphics. I think TYK2 will be the next big thing

Question: why no dermato trials? Mentioned in abstract & multiple times in text... huge unmet need there

Want to collaborate? Eric Morand 🇺🇦 Rohit Aggarwal Didem Saygin, MD

Super fun just reading through tweets of people celebrating match news #Match2024

So back to our question, does a biopsy with non-necrotizing granulomas diagnose sarcoidosis?

Not yet… Non-necrotizing granulomas have a broad differential including infection, malignancy, & inflammatory diseases (sarcoidosis). (3/n)

ncbi.nlm.nih.gov/pmc/articles/P…

PROMIS PROs are really awesome with several advantages over others. Congratulations to Shiri Keret, Raisa Lomanto Silva, MD Tanya Chandra for publishing the reliability, validity & responsiveness of PROMIS physical function 20 in Myositis. Use in myositis trials. doi.org/10.1093/rheuma…

Giving a talk about writing editorials... trying to find some 'Best of All Time' examples

Here's my top three! Care to share?

nejm.org/doi/full/10.10…
jamanetwork.com/journals/jama/…
nejm.org/doi/full/10.10…

Great talk Anisha Dua re:AAV, solid updates on mgmt decisions

Looking forward to debating this study with Mike Walsh w/Mats Junek moderating... Benjamin Terrier any updates on when your RWD study will be published?

Dr. John Cush